文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

早期血管加压素联合去甲肾上腺素对脓毒性休克短期死亡率的影响:基于MIMIC-IV数据库的回顾性研究

Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
PubMed 文献 · Am J Emerg Med · 2023-05-03
一句话结论在脓毒性休克成人患者中,早期(6小时内)启动血管加压素联合去甲肾上腺素与非早期启动相比,28天死亡率无显著差异(HR=0.91,95%CI 0.68-1.24)。

该回顾性单中心队列研究基于MIMIC-IV数据库,纳入531例脓毒性休克成人患者,按血管加压素是否在脓毒性休克发病6小时内启动分为早期组(331例,62.5%)和非早期组(200例,37.5%),经倾向性评分1:1匹配后两组各158例。主要终点28天死亡率在早期组与非早期组间无显著差异(HR=0.91,95%CI 0.68-1.24),ICU死亡率、住院死亡率、28天无升压药天数、无机械通气天数、ICU住院时间、住院时间、第2天和第3天SOFA评分及肾脏替代治疗使用均无差异。结论提示早期启动血管加压素联合去甲肾上腺素并未改善脓毒性休克患者的短期预后。

要点

  • 脓毒性休克患者早期(发病6小时内)启动血管加压素联合去甲肾上腺素,28天死亡率与非早期(发病至少6小时后)启动相比无显著差异(HR=0.91,95%CI 0.68-1.24)。
  • ICU死亡率(HR=0.95,95%CI 0.67-1.35)和住院死亡率(HR=0.95,95%CI 0.69-1.31)在早期与非早期组间亦无显著差异。
  • 28天无升压药天数、无机械通气天数、ICU住院时间、住院时间、第2天和第3天SOFA评分及第2天和第3天肾脏替代治疗使用在两组间均无差异。
  • 该研究为回顾性单中心队列研究,证据等级有限,结果不能作为床旁常规改变用药时机的依据。

适用人群与场景

  • 来自MIMIC-IV数据库的成人脓毒性休克患者,共531例,其中早期组331例(62.5%),非早期组200例(37.5%)。

诊断标准与关键阈值

  • 早期组定义为在脓毒性休克发病6小时内启动血管加压素,非早期组定义为在脓毒性休克发病至少6小时后启动血管加压素。

研究设计与关键结果

  • 研究类型:基于MIMIC-IV数据库的回顾性单中心队列研究,纳入531例成人脓毒性休克患者,比较早期(发病6小时内)与非早期(发病至少6小时后)启动血管加压素联合去甲肾上腺素的差异。
  • 主要终点:28天死亡率在早期组与非早期组间无显著差异(HR=0.91,95%CI 0.68-1.24)。
  • 次要终点:ICU死亡率(HR=0.95,95%CI 0.67-1.35)和住院死亡率(HR=0.95,95%CI 0.69-1.31)在两组间无显著差异;28天无升压药天数、无机械通气天数、ICU住院时间、住院时间、第2天和第3天SOFA评分、第2天和第3天肾脏替代治疗使用在两组间均无差异。
  • 倾向性评分匹配:按1:1匹配后,早期组158例与非早期组158例进行比较。

证据类型、等级与局限

  • 证据类型:回顾性单中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于脓毒性休克成人患者,早期(发病6小时内)启动血管加压素联合去甲肾上腺素与非早期启动相比,28天死亡率、ICU死亡率、住院死亡率及其他次要结局均无显著差异,不支持仅因时机因素而改变血管加压素的启动策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Septic shock is a leading cause of death in intensive care units (ICUs), with short-term mortality rates of 35-40%. Vasopressin (AVP) is a second-line vasoactive agent for septic shock, and recent studies suggest that early AVP use can be beneficial. However, differences between early initiation of AVP combined with norepinephrine (NE) and nonearly AVP with NE are unclear. A retrospective cohort research was designed to explore the effects of early AVP initiation versus nonearly AVP initiation.

METHODS: This retrospective single-center cohort study included adult patients with septic shock from the MIMIC (Medical Information Mart for Intensive Care)-IV database. According to whether AVP was used early in the ICU (intensive care unit), patients were assigned to the early- (within 6 h of septic shock onset) and non-early-AVP (at least 6 h after septic shock onset) groups. The primary outcome was 28-day mortality. The secondary outcomes were ICU and hospital mortality, the numbers of vasopressor-free and ventilation-free days at 28 days, ICU length of stay (LOS), hospital LOS, sequential organ failure assessment (SOFA) score on days 2 and 3, and renal replacement therapy (RRT) use on days 2 and 3. Univariate and multivariate cox proportional-hazards regression, propensity-score matching were used to analyze the differences between the groups.

RESULTS: The study included 531 patients with septic shock: 331 (62.5%) in the early-AVP group and 200 (37.5%) in the non-early-AVP group. For 1:1 matching, 158 patients in the early-AVP group were matched with the same number of patients with nonearly AVP. Regarding the primary outcome, there was no significant difference between the early- and non-early-AVP groups in 28-day mortality (hazard ratio [HR] = 0.91, 95% confidence interval [CI] = 0.68-1.24). For the secondary outcomes, there were no differences between the early- and non-early-AVP groups in ICU mortality (HR = 0.95, 95% CI = 0.67-1.35), hospital mortality (HR = 0.95, 95% CI = 0.69-1.31), the numbers of vasopressor-free and ventilation-free days at 28 days, ICU LOS, hospital LOS, SOFA score on days 2 and 3, and RRT use on days 2 and 3.

CONCLUSIONS: There was no difference in short-term mortality between early AVP combined with NE and nonearly AVP with NE in septic shock.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. He D, Zhang L, Hu H, et al. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database. Am J Emerg Med. 2023. PMID: 37167890. doi:10.1016/j.ajem.2023.04.040

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。